Fig. 5From: Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER-2-positive breast cancer based on the FAERS databaseThe number of adverse events reported by three anti-HER2 drugs in 27 SOCBack to article page
